Related Experiment Video
Updated: Jun 15, 2026
07:32
Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
Cancer cell-specific internalizing ligands from phage displayed beta-lactamase-peptide fusion libraries
1Department of Surgery and Vermont Cancer Center, University of Vermont College of Medicine, Burlington, VT 05405, USA. Girja.Shukla@uvm.edu
Protein Engineering, Design & Selection : PEDS
|March 12, 2010
Summary
Researchers developed a novel phage display method to identify cancer cell-specific internalizing ligands. This approach efficiently isolates beta-lactamase-peptide fusion proteins for cancer research and therapy.
Area of Science:
- Biotechnology
- Molecular Biology
- Cancer Research
Background:
- Phage display is a powerful tool for identifying specific binding molecules.
- Targeted cancer therapies require ligands that can specifically bind and internalize into cancer cells.
Purpose of the Study:
- To develop and utilize a novel phage display library for identifying cancer cell-specific internalizing ligands.
- To create fusion proteins of beta-lactamase and peptides for efficient screening and potential therapeutic applications.
Main Methods:
- A new phage display library was constructed, fusing linear or cysteine-constrained random peptides to catalytically active P99 beta-lactamase.
- The library was selected against live BT-474 human breast cancer cells to isolate specific binding and internalizing ligands.
- Screening of clones was facilitated by the beta-lactamase fusion, simplifying the process.
Main Results:
- Several cancer cell-specific binding and internalizing beta-lactamase-peptide fusion ligands were successfully isolated.
- Identified ligands shared common motifs, suggesting selectivity for shared cancer cell targets.
- The selected ligands are directly usable for tracking applications without further modification.
Conclusions:
- This study presents the first report of selecting cell-internalized enzyme conjugates using phage display technology.
- The developed method offers an efficient and simple approach for isolating cancer-specific peptides.
- These ligands hold potential for targeted enzyme prodrug therapy and other cell-specific delivery protocols.
